Date Filed | Type | Description |
02/09/2021 |
GN
| Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021 |
10/22/2020 |
GN
| Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020 |
10/21/2020 |
GN
| Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints |
09/08/2020 |
GN
| Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors |
09/03/2020 |
GN
| Anika to Participate in Upcoming Virtual Investor Conferences |
08/05/2020 |
GN
| Anika Appoints Michael Levitz as Chief Financial Officer |
07/20/2020 |
GN
| Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020 |
07/16/2020 |
GN
| Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30 |
02/20/2020 |
GN
| Anika Reports Fourth Quarter and Full Year 2019 Financial Results |
01/29/2020 |
GN
| Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer |
11/21/2019 |
GN
| Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform |
04/08/2019 |
GN
| Recent Analysis Shows Renewable Energy Group, Winnebago Industries, Ambac Financial Group, Hibbett Sports, AmeriGas Partners, and Anika Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth |
02/01/2019 |
GN
| New Research: Key Drivers of Growth for Cisco, Landstar System, Central Garden & Pet, Anika Therapeutics, Hibbett Sports, and MoneyGram International — Factors of Influence, Major Initiatives and Sustained Production |
08/07/2018 |
GN
| Analysis: Positioning to Benefit within Anika Therapeutics, Ameris, Century Communities, Energous, Consolidated Communications, and Globalstar — Research Highlights Growth, Revenue, and Consolidated Results |
05/02/2018 |
BW
| Anika Reports First Quarter 2018 Financial Results |
05/01/2018 |
GN
| Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical — Future Expectations, Projections Moving into 2018 |
04/18/2018 |
BW
| Anika to Issue First-Quarter 2018 Financial Results and Business Highlights on Wednesday, May 2 |
03/05/2018 |
GN
| Joseph Darling Named CEO and Director of Anika Therapeutics |
02/21/2018 |
BW
| Anika Reports Fourth Quarter and Full Year 2017 Financial Results |
02/07/2018 |
BW
| Anika to Issue Fourth-Quarter 2017 Financial Results and Business Highlights on Wednesday, February 21 |
01/22/2018 |
GN
| Recent Analysis Shows Darling Ingredients, Principal Financial Group, UGI, Cass Information, WD-40, and Anika Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth |
10/25/2017 |
BW
| Anika Reports Third Quarter 2017 Financial Results |
10/11/2017 |
BW
| Anika to Issue Third-Quarter 2017 Financial Results and Business Highlights on Wednesday, October 25 |
07/26/2017 |
BW
| Anika Reports Strong Second Quarter 2017 Financial Results |
07/12/2017 |
BW
| Anika to Issue Second-Quarter 2017 Financial Results and Business Highlights on Wednesday, July 26 |
04/19/2017 |
BW
| Anika to Issue First-Quarter 2017 Financial Results and Business Highlights on Wednesday, May 3 |
02/27/2017 |
GN
| Anika Therapeutics, Inc., (Nasdaq: ANIK) to Ring The Nasdaq Stock Market Opening Bell |
02/15/2017 |
BW
| Anika Reports Fourth Quarter and Full Year 2016 Financial Results |